CCL2 and Alzheimer disease: Elevated MCP1/CCL2 levels in both CSF and blood are consistently observed in FTD compared to healthy controls but show no significant differences between FTD and AD, positioning MCP1/CCL2 as a general marker of neuroinflammation.